Drug(薬物リスト) DrugBank | All Description Patterns

e.g. "Sirolimus", "アダリムマブ"

ABCDEFGH I JKLMNOPQRSTUVWXYZother

620 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG
💬 Info on mouse-over
KEGG GENES
💬 Info on mouse-over
KEGG PATHWAY 指定難病告示番号
💬 Info on mouse-over
1 (-)-epicatechin Epicatechin - - - 2件: 86, 113 💬
2 (pyr1)apelin-13 - - - - 1件: 86 💬
3 (s)-2-(4,6-dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid - - - - 1件: 86 💬
4 (s)-3-((3-(1-((6-(3,4-dimethoxyphenyl)pryazin-2-yl)amino)ethyl)phenyl)carbamoyl)-5-methylpridin-1-ium - - - - 1件: 86 💬
5 **comment**- imp inhalation solution identical to ventavis inhalation solution, but imp is in a different volume presentation. please see covering letter. - - - - 1件: 86 💬
6 10-nitro-9(e)-octadec-9-enoic acid - - - - 1件: 86 💬
7 11c-acetate Acetate - - - 3件: 13, 86, 88 💬
8 120 mg sodium nitrite inhalation solution Nitrite - - - 1件: 86 💬
9 15 mg sodium nitrite inhalation solution Nitrite - - - 1件: 86 💬
10 150mg cxa-10 CXA-10 - - - 1件: 86 💬
11 171 - - - - 1件: 86 💬
12 2-(4-[5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy)-n-(methylsulfonyl)actamide - - - - 1件: 86 💬
13 2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-n-(methylsulfonyl) acetamide Acetamide - - - 1件: 86 💬
14 20 mg sildenafil citrate by mouth Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
15 25% mtd sodium nitrite inhalation solution Nitrite - - - 1件: 86 💬
16 45 mg sodium nitrite inhalation solution Nitrite - - - 1件: 86 💬
17 4au76 - - - - 1件: 86 💬
18 66215-101 - - - - 1件: 86 💬
19 6r-bh4 Sapropterin 1件: D08505 💬 - - 3件: 86, 124, 240 💬
20 75mg cxa-10 CXA-10 - - - 1件: 86 💬
21 90 mg sodium nitrite inhalation solution Nitrite - - - 1件: 86 💬
22 : 2-{4-[(5,6-difenilpirazin-2-yl)(isopropil)amino]butoxi}-n- - - - - 1件: 86 💬
23 [11c]-gsk2256098 500 mbq GSK2256098 - - - 1件: 86 💬
24 [18f] fes - - - - 1件: 86 💬
25 [18f]fluoro-2-deoxy-2-d-glucose D-glucose 1件: D00009 💬 - - 2件: 86, 88 💬
26 Abi-009, nab-rapamycin, albumin-bound rapamycin Sirolimus 1件: D00753 💬 1件: MTOR 💬 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 1件: 86 💬
27 Access program - sildenafil citrate, viagra, revatio Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
28 Ace-011 - - - - 1件: 86 💬
29 Acetamide Acetamide - - - 1件: 86 💬
30 Acetaminophen Acetaminophen 1件: D00217 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 14件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
31 Acetate Acetate - - - 43件: 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
32 Act - 064992 - - - - 1件: 86 💬
33 Act-050089 - - - - 1件: 86 💬
34 Act-050089 (ro 61-0612) - - - - 1件: 86 💬
35 Act-064992 - - - - 5件: 51, 85, 86, 88, 210 💬
36 Act-064992d - - - - 1件: 86 💬
37 Act-178418 - - - - 1件: 86 💬
38 Act-293987 - - - - 3件: 51, 86, 88 💬
39 Act-293987 (ns-304) - - - - 1件: 86 💬
40 Act-385781a - - - - 1件: 86 💬
41 Act-385781a (actelion epoprostenol) Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
42 Actriia-igg1fc - - - - 1件: 86 💬
43 Adcirca - - - - 1件: 86 💬
44 Adcirca 20 mg film-coated tablets - - - - 1件: 86 💬
45 Adcirca® - - - - 1件: 86 💬
46 Adempas - - - - 5件: 51, 86, 88, 225, 299 💬
47 Adempas (riociguat, bay63-2521) Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 2件: 86, 88 💬
48 Adempas - 0,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 1件: 86 💬
49 Adempas - 1 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 2件: 51, 86 💬
50 Adempas - 1,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 2件: 51, 86 💬
51 Adempas - 2 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 2件: 51, 86 💬
52 Adempas - 2,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 2件: 51, 86 💬
53 Adempas 0.5 mg - - - - 2件: 86, 299 💬
54 Adempas 0.5 mg film coated tablet - - - - 1件: 86 💬
55 Adempas 1 mg film coated tablet - - - - 1件: 86 💬
56 Adempas 1.0 mg - - - - 2件: 86, 299 💬
57 Adempas 1.5 mg - - - - 1件: 86 💬
58 Adempas 1.5 mg film coated tablet - - - - 1件: 86 💬
59 Adempas 2 mg film coated tablet - - - - 1件: 86 💬
60 Adempas 2.0 mg - - - - 2件: 86, 299 💬
61 Adempas 2.5 mg - - - - 1件: 86 💬
62 Adempas 2.5 mg film coated tablet - - - - 1件: 86 💬
63 Adempas® - - - - 2件: 86, 88 💬
64 Adempas® 0.5 mg film-coated tablets - - - - 1件: 86 💬
65 Adempas® 1.0 mg film-coated tablets - - - - 1件: 86 💬
66 Adempas® 1.5 mg film-coated tablets - - - - 1件: 86 💬
67 Adempas® 2.0 mg film-coated tablets - - - - 1件: 86 💬
68 Adempas® 2.5 mg film-coated tablets - - - - 1件: 86 💬
69 Adempas¿ 0.5 mg compressa rivestita con film - - - - 1件: 86 💬
70 Adempas¿ 1.0 - - - - 1件: 86 💬
71 Adempas¿ 1.5 mg - - - - 1件: 86 💬
72 Adempas¿ 2.0 mg - - - - 1件: 86 💬
73 Adempas¿ 2.5 mg - - - - 1件: 86 💬
74 Adipose derived mesenchymal stem cells - - - - 1件: 86 💬
75 Aerosolized iloprost Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
76 Air001 - - - - 1件: 86 💬
77 Air001 (sodium nitrite inhalation solution) Nitrite - - - 1件: 86 💬
78 Air001 inhalation solution - - - - 1件: 86 💬
79 Air001 inhalation solution (expansion arm) - - - - 1件: 86 💬
80 Al - - - - 9件: 5, 6, 7, 28, 51, 67, 86, 114, 127 💬
81 Albuterol Salbutamol 1件: D02147 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 8件: 12, 13, 86, 89, 113, 231, 256, 299 💬
82 Albuterol first Salbutamol 1件: D02147 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
83 Albuterol. Salbutamol 1件: D02147 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
84 Allogeneic human cardiosphere-derived stem cells - - - - 1件: 86 💬
85 Ambrisentan Ambrisentan 1件: D07077 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 7件: 51, 84, 85, 86, 88, 210, 211 💬
86 Ambrisentan - high dose Ambrisentan 1件: D07077 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
87 Ambrisentan - low dose Ambrisentan 1件: D07077 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
88 Ambrisentan 5 mg film-coated tablets Ambrisentan 1件: D07077 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
89 Ambrisentan 5mg film-coated tablets [marketed product] Ambrisentan 1件: D07077 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
90 Ambrisentan plus spironolactone Ambrisentan 2件: D00443, D07077 💬 2件: EDNRA, NR3C2 💬 8件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
91 Ambrisentan tablet Ambrisentan 1件: D07077 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
92 Ammonia Ammonia 1件: D02916 💬 - - 4件: 6, 17, 86, 88 💬
93 Amn107 - - - - 2件: 34, 86 💬
94 Anakinra Anakinra 1件: D02934 💬 2件: IL1R1, IL1R2 💬 15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 17件: 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬
95 Anastrozole Anastrozole 1件: D00960 💬 1件: CYP19A1 💬 3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 3件: 78, 86, 193 💬
96 Angiotensin Angiotensin II 2件: D00150, D02014 💬 2件: AGTR1, AGTR2 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 7件: 17, 19, 46, 66, 86, 222, 224 💬
97 Apabetalone Apabetalone 1件: D11131 💬 - - 1件: 86 💬
98 Apd811 - - - - 1件: 86 💬
99 Apelin - - - - 1件: 86 💬
100 Apn01 Recombinant Human Angiotensin-Converting Enzyme 2 - - - 1件: 86 💬
101 Ar392830 - - - - 1件: 86 💬
102 Aspirin Acetylsalicylic acid 1件: D00109 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 11件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231 💬
103 Assigned pulmonary hypertension medication - - - - 1件: 86 💬
104 Autologous epcs transfected - - - - 1件: 86 💬
105 Autologous epcs transfected with human enos - - - - 1件: 86 💬
106 Aviptadil Aviptadil - - - 4件: 49, 51, 85, 86 💬
107 Azd4831 - - - - 1件: 86 💬
108 Bardoxolone Bardoxolone 1件: D09584 💬 - - 7件: 66, 67, 84, 85, 86, 218, 222 💬
109 Bardoxolone methyl Bardoxolone 2件: D09584, D09585 💬 - - 7件: 66, 67, 84, 85, 86, 218, 222 💬
110 Bardoxolone methyl capsules Bardoxolone 2件: D09584, D09585 💬 - - 4件: 66, 67, 86, 222 💬
111 Bardoxolone methyl, cddo-me, cddo-methyl ester, nsc 713200, chemical name: oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester Bardoxolone 2件: D09584, D09585 💬 - - 1件: 86 💬
112 Bay 63-2521 - - - - 2件: 86, 88 💬
113 Bay 63-2521 0.06 % - - - - 1件: 86 💬
114 Bay 63-2521 0.3 % - - - - 1件: 86 💬
115 Bay 63-2521 coated tablets 0.5 mg - - - - 2件: 86, 88 💬
116 Bay 63-2521 coated tablets 1 mg - - - - 2件: 86, 88 💬
117 Bay 63-2521 coated tablets 1.5 mg - - - - 2件: 86, 88 💬
118 Bay 63-2521 coated tablets 2 mg - - - - 2件: 86, 88 💬
119 Bay 63-2521 coated tablets 2.5 mg - - - - 2件: 86, 88 💬
120 Bay 63-2521 ir tablets 0.5 mg - - - - 1件: 86 💬
121 Bay 63-2521 ir tablets 1 mg - - - - 1件: 86 💬
122 Bay 63-2521 ir tablets 1.0 mg - - - - 1件: 86 💬
123 Bay 63-2521 ir tablets 1.5 mg - - - - 1件: 86 💬
124 Bay 63-2521 ir tablets 2.0 mg - - - - 1件: 86 💬
125 Bay 63-2521 ir tablets 2.5 mg - - - - 1件: 86 💬
126 Bay 63-2521 tablet - - - - 1件: 86 💬
127 Bay 63-2521 tablets 0.5 mg - - - - 2件: 86, 88 💬
128 Bay 63-2521 tablets 1 mg - - - - 2件: 86, 88 💬
129 Bay 63-2521 tablets 1.5 mg - - - - 2件: 86, 88 💬
130 Bay 63-2521 tablets 2 mg - - - - 2件: 86, 88 💬
131 Bay 63-2521 tablets 2.5 mg - - - - 2件: 86, 88 💬
132 Bay q 6256 - - - - 1件: 86 💬
133 Bay1237592 - - - - 2件: 86, 88 💬
134 Bay63-2521 - - - - 3件: 51, 86, 299 💬
135 Beetroot juice - - - - 1件: 86 💬
136 Benzbromaron - - - - 1件: 86 💬
137 Benzbromaron al - - - - 1件: 86 💬
138 Benzbromarone Benzbromarone 1件: D01056 💬 - - 1件: 86 💬
139 Beraprost Beraprost 1件: D02720 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
140 Beraprost sodium Beraprost 1件: D02720 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
141 Beraprost sodium 314d modified release tablets Beraprost 1件: D02720 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
142 Beraprost sodium modified release Beraprost 1件: D02720 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
143 Bevacizumab Bevacizumab 1件: D06409 💬 1件: VEGFA 💬 22件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
144 Bh4 - - - - 5件: 51, 86, 124, 240, 299 💬
145 Bia BIA - - - 2件: 6, 86 💬
146 Bia 5-1058 BIA - - - 1件: 86 💬
147 Bia-5-1058 BIA - - - 1件: 86 💬
148 Biological dmards - - - - 1件: 86 💬
149 Bisoprolol Bisoprolol 2件: D00634, D02342 💬 1件: ADRB1 💬 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 3件: 67, 86, 113 💬
150 Blood test - - - - 5件: 36, 86, 113, 162, 299 💬
151 Bosentan Bosentan 2件: D01227, D07538 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
152 Bosentan administration Bosentan 2件: D01227, D07538 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
153 Bosentan and sildenafil Bosentan 4件: D01227, D02229, D07538, D08514 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
154 Bosentan monohidrato Bosentan 2件: D01227, D07538 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
155 Bosentan monohydrat Bosentan 2件: D01227, D07538 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
156 Bosentan monohydrate Bosentan 2件: D01227, D07538 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 4件: 51, 84, 86, 88 💬
157 Bosentan, ambrisentan Ambrisentan 3件: D01227, D07077, D07538 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
158 Bps-314d-mr - - - - 1件: 86 💬
159 Bps-mr - - - - 1件: 86 💬
160 Bromure d'ipratropium Ipratropium 1件: D02212 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件: 86 💬
161 Bsf 208075 - - - - 1件: 86 💬
162 Bsf 208075 or lu 208075 - - - - 1件: 86 💬
163 C07ab07 - - - - 1件: 86 💬
164 C225 - - - - 2件: 51, 86 💬
165 Capsaicin Capsaicin 1件: D00250 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 5件: 2, 6, 19, 86, 226 💬
166 Captopril Captopril 1件: D00251 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 2件: 17, 86 💬
167 Carbon Activated charcoal 1件: D03251 💬 - - 9件: 6, 46, 50, 51, 85, 86, 96, 97, 298 💬
168 Carbon monoxide Activated charcoal 2件: D03251, D09706 💬 - - 3件: 85, 86, 298 💬
169 Carvedilol Carvedilol 2件: D00255, D03415 💬 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 5件: 6, 57, 86, 113, 210 💬
170 Cetuximab Cetuximab 1件: D03455 💬 1件: EGFR 💬 46件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 5件: 34, 51, 86, 89, 331 💬
171 Chlorhexidine Chlorhexidine 4件: D00858, D01345, D03463, D07668 💬 - - 2件: 86, 299 💬
172 Cialis - - - - 2件: 51, 86 💬
173 Cialis 10 mg film-coated tablets - - - - 2件: 86, 113 💬
174 Cialis 2.5 mg film-coated tablets - - - - 2件: 86, 113 💬
175 Cialis 20 mg comprimidos recubiertos con película - - - - 1件: 86 💬
176 Cialis 20 mg film-coated tablets - - - - 2件: 86, 113 💬
177 Cialis 5 mg film-coated tablets - - - - 2件: 86, 113 💬
178 Cicletanine Cicletanine 1件: D03487 💬 - - 1件: 86 💬
179 Cicletanine hydrochloride Cicletanine 1件: D03487 💬 - - 1件: 86 💬
180 Citrulline Citrulline 1件: D07706 💬 - - 2件: 86, 113 💬
181 Cjnj-68150420-zzz-g001 (act- 064992d) - - - - 1件: 86 💬
182 Cjnj-68150420-zzz-g001 (act-064992d) - - - - 1件: 86 💬
183 Cjnj-68150420-zzz-g001(act-064992d) - - - - 1件: 86 💬
184 Clopidogrel Clopidogrel 4件: D00769, D07729, D10823, D10824 💬 1件: P2RY12 💬 1件: Platelet activation 2件: 49, 86 💬
185 Coenzyme q-10 Ubidecarenone 1件: D01065 💬 - - 1件: 86 💬
186 Coenzyme q-10 in normal control subjects Ubidecarenone 1件: D01065 💬 - - 1件: 86 💬
187 Coenzyme q-10 in pulmonary hypertension subjects Ubidecarenone 1件: D01065 💬 - - 1件: 86 💬
188 Combination product: device: axially oscillating sphere dry powder inhaler (aos dpi) - - - - 1件: 86 💬
189 Combination product: implantable system for remodulin (treprostinil) Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
190 Combination product: treprostinil via implanted pump Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
191 Commercial ventavis® (iloprost) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
192 Conivaptan Conivaptan 2件: D01236, D07748 💬 2件: AVPR1A, AVPR2 💬 5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 1件: 86 💬
193 Conventional drug therapy(expectorant,bronchodilator) - - - - 1件: 86 💬
194 Cosmofer - - - - 3件: 86, 96, 97 💬
195 Current marketed flolan (epoprostenol sodium) Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
196 Cxa-10 CXA-10 - - - 2件: 86, 222 💬
197 D-glucose D-glucose 1件: D00009 💬 - - 3件: 49, 86, 88 💬
198 Device: breelib nebulizer - - - - 1件: 86 💬
199 Device: crono five ambulatory pump - - - - 1件: 86 💬
200 Device: endopat measurement - - - - 1件: 86 💬
201 Device: generic dry powder inhaler - - - - 1件: 86 💬
202 Device: i-neb aad system - - - - 1件: 86 💬
203 Device: l606 inhalation system - - - - 1件: 86 💬
204 Device: mhealth intervention - - - - 1件: 86 💬
205 Device: usual care - - - - 1件: 86 💬
206 Dhea Prasterone 1件: D08409 💬 3件: AR, ESR1, ESR2 💬 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 3件: 49, 86, 96 💬
207 Dhea tablet Prasterone 1件: D08409 💬 3件: AR, ESR1, ESR2 💬 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 1件: 86 💬
208 Diagnostic test: cardiac mri (gadolinium enhanced) Gadolinium - - - 1件: 86 💬
209 Diagnostic test: cmri - - - - 2件: 51, 86 💬
210 Diagnostic test: endogenous thrombin potential Thrombin 1件: D00090 💬 - - 2件: 86, 88 💬
211 Diagnostic test: light transmission aggregometry - - - - 2件: 86, 88 💬
212 Diagnostic test: pet-ct imaging with [89zr]-bevacizumab Bevacizumab 1件: D06409 💬 1件: VEGFA 💬 22件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 1件: 86 💬
213 Diagnostic test: platelet function analyzer-100 - - - - 2件: 86, 88 💬
214 Diagnostic test: rotational thromboelastometry - - - - 2件: 86, 88 💬
215 Dichloroacetate Dichloroacetic acid - - - 1件: 86 💬
216 Dichloroacetate sodium Dichloroacetic acid - - - 1件: 86 💬
217 Dietanolamina de treprostinilo Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
218 Diltiazem Diltiazem 3件: D00616, D03830, D07845 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 3件: 51, 58, 86 💬
219 Diltiazem hydrochloride Diltiazem 3件: D00616, D03830, D07845 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
220 Dimethyl fumarate Dimethyl fumarate 1件: D03846 💬 1件: KEAP1 💬 4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis 4件: 13, 51, 86, 296 💬
221 Dimethyl fumarate (dmf) Dimethyl fumarate 1件: D03846 💬 1件: KEAP1 💬 4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis 3件: 13, 51, 86 💬
222 Diphenhydramine Diphenhydramine 6件: D00300, D00669, D02419, D03285, D03360, D03854 💬 1件: HRH1 💬 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 8件: 11, 49, 51, 70, 86, 96, 222, 256 💬
223 Duo-therapy with sildenafil + bosentan Bosentan 4件: D01227, D02229, D07538, D08514 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
224 Efi/act-385781a - - - - 1件: 86 💬
225 Elafin Elafin - - - 1件: 86 💬
226 Endothelin receptor antagonist therapy - - - - 1件: 86 💬
227 Endothelin-3 - - - - 1件: 86 💬
228 Enos transfected epcs will be delivered via a pa line - - - - 1件: 86 💬
229 Epicatechin Epicatechin - - - 2件: 86, 113 💬
230 Epoprostenol Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
231 Epoprostenol for injection Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
232 Epoprostenol sodico Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
233 Epoprostenol sodium Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
234 Epoprostenol-actelion Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
235 Epoprostenolo per iniezione - - - - 1件: 86 💬
236 Equal - - - - 5件: 6, 13, 67, 86, 230 💬
237 Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan) Bosentan 6件: D01227, D02008, D02229, D07538, D08514, D10135 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
238 Era as specific pah treatment - - - - 1件: 86 💬
239 Erbitux - - - - 2件: 51, 86 💬
240 Esomeprazole Esomeprazole 4件: D01984, D04056, D07917, D09339 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 6件: 13, 46, 86, 98, 298, 299 💬
241 Esr-specific pet scan - - - - 1件: 86 💬
242 Esuberaprost - - - - 1件: 86 💬
243 Eutonic treprostinil solution Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
244 Famotidine Famotidine 1件: D00318 💬 1件: HRH2 💬 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 4件: 6, 46, 86, 98 💬
245 Famotidine 20 mg Famotidine 1件: D00318 💬 1件: HRH2 💬 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 1件: 86 💬
246 Fdc macitentan/tadalafil Macitentan 2件: D02008, D10135 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
247 Ferinject - - - - 2件: 86, 299 💬
248 Ferinject or cosmofer - - - - 1件: 86 💬
249 Ferric carboxymaltose Ferric carboxymaltose 1件: D08920 💬 - - 4件: 86, 96, 97, 299 💬
250 Ferricarboxymaltose - - - - 1件: 86 💬
251 Fk506 level 2-3 ng/ml - - - - 1件: 86 💬
252 Fk506 level 3-5 ng/ml - - - - 1件: 86 💬
253 Fk506 level < 2 ng/ml - - - - 1件: 86 💬
254 Flolan - - - - 1件: 86 💬
255 Flolan injection with currently marketed diluent - - - - 1件: 86 💬
256 Flolan injection with reformulated diluent - - - - 1件: 86 💬
257 Flolan tm and glycine diluent Glycine 1件: D00011 💬 - - 1件: 86 💬
258 Flolan® - - - - 1件: 86 💬
259 Flolan™ and glycine diluent Glycine 1件: D00011 💬 - - 1件: 86 💬
260 Fluoxetine Fluoxetine 2件: D00326, D00823 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 4件: 13, 17, 78, 86 💬
261 Fulvestrant Fulvestrant 1件: D01161 💬 2件: ESR1, ESR2 💬 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 1件: 86 💬
262 G04be03 - - - - 1件: 86 💬
263 G04be03- sildenafil - sildenafil (citrato) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
264 Gadolinium Gadolinium - - - 6件: 13, 34, 46, 58, 65, 86 💬
265 Gb002 - - - - 1件: 86 💬
266 Gb002 capsules - - - - 1件: 86 💬
267 Glivec - - - - 2件: 51, 86 💬
268 Glivec 100 mg comprimidos recubiertos con película - - - - 2件: 34, 86 💬
269 Glivec 100 mg filmtabletten - - - - 2件: 51, 86 💬
270 Glivec 100 mg hartkapsel - - - - 1件: 86 💬
271 Glivec® - - - - 1件: 86 💬
272 Glivec® 100 mg filmtabletten - - - - 1件: 86 💬
273 Glucose Dextrose, unspecified form - - - 15件: 2, 6, 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬
274 Glycine Glycine 1件: D00011 💬 - - 5件: 35, 60, 86, 226, 299 💬
275 Gma301 injection - - - - 1件: 86 💬
276 Gold Gold - - - 38件: 2, 5, 6, 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬
277 Gradient - - - - 4件: 58, 86, 149, 215 💬
278 Gs-4997 18 mg - - - - 1件: 86 💬
279 Gs-4997 2 mg - - - - 1件: 86 💬
280 Gs-4997 6 mg - - - - 1件: 86 💬
281 Gsk1325760 - - - - 2件: 86, 88 💬
282 Gsk1325760a - - - - 1件: 86 💬
283 Gsk2256098 GSK2256098 - - - 1件: 86 💬
284 Gsk2586881 - - - - 1件: 86 💬
285 Hgp1206 - - - - 1件: 86 💬
286 Hydroxyurea Hydroxyurea 1件: D00341 💬 1件: RRM2 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 8件: 3, 13, 19, 20, 65, 85, 86, 284 💬
287 Hypotonictreprostinil solution - - - - 1件: 86 💬
288 I.v. selexipag Selexipag 1件: D09994 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
289 Ifetroban Ifetroban 1件: D04500 💬 1件: TBXA2R 💬 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 3件: 51, 86, 113 💬
290 Ilomedin 20 - - - - 1件: 86 💬
291 Ilomedin 20 [20 µg / ml] - - - - 1件: 86 💬
292 Iloprost Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 4件: 51, 84, 85, 86 💬
293 Iloprost (5 µg) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
294 Iloprost (ventavis bayq6256) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
295 Iloprost (ventavis inhaled, bayq6256) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
296 Iloprost (ventavis, bayq 6256) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
297 Iloprost (ventavis, bayq6256) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
298 Iloprost (ventavis®) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
299 Iloprost inhalation solution (ventavis) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 2件: 85, 86 💬
300 Iloprost pd-15 Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
301 Iloprost pd-6 Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
302 Iloprost,(ventavis, bayq6256) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
303 Imatinib Imatinib 2件: D01441, D08066 💬 3件: ABL1, KIT, PDGFRA 💬 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
304 Imatinib mesilate Imatinib 2件: D01441, D08066 💬 3件: ABL1, KIT, PDGFRA 💬 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 3件: 13, 86, 88 💬
305 Imatinib mesylate Imatinib 2件: D01441, D08066 💬 3件: ABL1, KIT, PDGFRA 💬 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 5件: 13, 28, 34, 51, 86 💬
306 Inhaled dry powder treprostinil (liq861) Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
307 Inhaled iloprost (5 µg) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
308 Inhaled iloprost (ventavis, bayq6256) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
309 Inhaled nitric oxide Nitric Oxide 1件: D00074 💬 - - 2件: 85, 86 💬
310 Inhaled nitric oxide & inopulse delivery Nitric Oxide 1件: D00074 💬 - - 1件: 86 💬
311 Inhaled nitric oxide 75 mcg/kg ibw/hr Nitric Oxide 1件: D00074 💬 - - 2件: 85, 86 💬
312 Inhaled no with pulsed delivery - - - - 1件: 86 💬
313 Inhaled prostacyclin Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
314 Inhaled treprostinil Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 2件: 84, 86 💬
315 Ino - - - - 2件: 85, 86 💬
316 Intravenous administration of ferric carboxymaltose Ferric carboxymaltose 1件: D08920 💬 - - 1件: 86 💬
317 Intravenous treprostinil Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
318 Intravenous/subcutaneous treprostinil Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
319 Ipratropium Ipratropium 1件: D02212 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 2件: 6, 86 💬
320 Iron supplement - - - - 1件: 86 💬
321 Jnj-67896049 - - - - 1件: 86 💬
322 Jnj-67896049 (act-293987) - - - - 1件: 86 💬
323 Jnj-67896062 / act-064992 - - - - 2件: 86, 88 💬
324 Jtt-251 - - - - 1件: 86 💬
325 Kar5585 capsules - - - - 1件: 86 💬
326 L-citrulline malate Citrulline 1件: D07706 💬 - - 1件: 86 💬
327 L606 (liposomal treprostinil) inhalation solution 51ug Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
328 Levitra - - - - 2件: 13, 86 💬
329 Lidocaine Lidocaine 3件: D00358, D02086, D08127 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 10件: 6, 13, 34, 46, 51, 86, 168, 226, 231, 256 💬
330 Liq861 100 µg - - - - 1件: 86 💬
331 Liq861 106 µg - - - - 1件: 86 💬
332 Liq861 25 µg - - - - 1件: 86 💬
333 Liq861 26.5 µg - - - - 1件: 86 💬
334 Liq861 50 µg - - - - 1件: 86 💬
335 Liq861 53 µg - - - - 1件: 86 💬
336 Liq861 75 µg - - - - 1件: 86 💬
337 Liq861 79.5 µg - - - - 1件: 86 💬
338 Liq861 inhaled treprostinil Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
339 Lisuride Lisuride 2件: D01462, D08132 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 2件: 6, 86 💬
340 Lloprost(ventavis,bayq6252, 10 µg/ml) - - - - 1件: 86 💬
341 Lloprost(ventavis,bayq6252, 20 µg/ml) - - - - 1件: 86 💬
342 Ly450190 - - - - 1件: 86 💬
343 Macitentan Macitentan 1件: D10135 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 5件: 51, 85, 86, 88, 210 💬
344 Macitentan (act-064992) Macitentan 1件: D10135 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
345 Macitentan 10 mg Macitentan 1件: D10135 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 3件: 51, 86, 88 💬
346 Macitentan 10 mg tablet, once daily. Macitentan 1件: D10135 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
347 Macitentan 37.5 mg Macitentan 1件: D10135 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
348 Macitentan 75 mg Macitentan 1件: D10135 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
349 Macitentan group Macitentan 1件: D10135 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
350 Macitentan tablets Macitentan 1件: D10135 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 2件: 86, 88 💬
351 Md-711 - - - - 1件: 86 💬
352 Medical air Medical air - - - 3件: 85, 86, 193 💬
353 Metformin Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 21件: 2, 6, 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
354 Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo - - - - 1件: 86 💬
355 Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb - - - - 2件: 86, 88 💬
356 Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1h-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth - - - - 2件: 86, 88 💬
357 Methylprednisolone Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 44件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
358 Mk-5475 - - - - 1件: 86 💬
359 Mk-8892 - - - - 1件: 86 💬
360 Monitor Methamidophos - - - 18件: 2, 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬
361 Mono-therapy with sildenafil Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
362 Morphine Morphine 3件: D00842, D02271, D08233 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 5件: 36, 46, 70, 85, 86 💬
363 Morphine sulfate Morphine 3件: D00842, D02271, D08233 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 3件: 46, 85, 86 💬
364 Moxifloxacin Moxifloxacin 2件: D00874, D08237 💬 - - 8件: 2, 6, 46, 49, 85, 86, 240, 299 💬
365 Moxifloxacin 400 mg Moxifloxacin 2件: D00874, D08237 💬 - - 1件: 86 💬
366 Multihance - - - - 2件: 86, 88 💬
367 Nebulized combination ipratropium bromide with salbutamol Ipratropium 2件: D02147, D02212 💬 6件: ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 17件: Adrenergic signaling in cardiomyocytes, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
368 Nebulized ipratropium bromide Ipratropium 1件: D02212 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件: 86 💬
369 New thermo stable formulation of epoprostenol sodium Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
370 Nicardipine Nicardipine 2件: D00617, D08270 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 2件: 70, 86 💬
371 Nilotinib Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 5件: 6, 8, 34, 51, 86 💬
372 Nilotinib 50 mg Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 1件: 86 💬
373 Nitric oxide Nitric Oxide 1件: D00074 💬 - - 8件: 46, 85, 86, 98, 210, 251, 294, 299 💬
374 Nitric oxide for inhalation Nitric Oxide 1件: D00074 💬 - - 2件: 86, 299 💬
375 Nitric oxide generated by the geno nitrosyl delivery system Nitric Oxide 1件: D00074 💬 - - 1件: 86 💬
376 Nitric oxide plus oxygen Nitric Oxide 2件: D00003, D00074 💬 - - 1件: 86 💬
377 Nitrite Nitrite - - - 2件: 86, 299 💬
378 Nitrosyl Nitric Oxide 1件: D00074 💬 - - 1件: 86 💬
379 Non-biologic dmards - - - - 2件: 46, 86 💬
380 Ns-304 - - - - 3件: 70, 86, 88 💬
381 Null - - - - 16件: 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬
382 Nx1011 - - - - 1件: 86 💬
383 Observational study with patients treated with tracleer, ventavis, veletri, opsumit and/or uptravi - - - - 1件: 86 💬
384 Olaparib Olaparib 1件: D09730 💬 2件: PARP1, PARP2 💬 5件: Apoptosis, Base excision repair, Diabetic cardiomyopathy, NF-kappa B signaling pathway, Necroptosis 2件: 86, 285 💬
385 Opsumit - - - - 3件: 86, 88, 210 💬
386 Opsumit (macitentan) Macitentan 1件: D10135 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
387 Opsumit® - - - - 3件: 86, 88, 210 💬
388 Oral anticoagulant treatment - - - - 1件: 86 💬
389 Oral era - - - - 1件: 86 💬
390 Oral ifetroban Ifetroban 1件: D04500 💬 1件: TBXA2R 💬 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 2件: 51, 86 💬
391 Oral pde5 inhibitors - - - - 1件: 86 💬
392 Oral selexipag (uptravi) Selexipag 1件: D09994 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
393 Oral sildenafil Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
394 Oral treprostinil Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 2件: 51, 86 💬
395 Oral treprostinil (ut-15c) sustained release tablets Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
396 Other: iloprost (ventavis inhaled, bayq6256) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
397 Other: noninvasive actigraphy monitor Methamidophos - - - 1件: 86 💬
398 Other: oxygen supplementation Oxygen 1件: D00003 💬 - - 1件: 86 💬
399 Other: standard-of-care - - - - 1件: 86 💬
400 Other: standardized meals - - - - 1件: 86 💬
401 Other: subacute hypoxic exposures - - - - 1件: 86 💬
402 Oxygen Oxygen 1件: D00003 💬 - - 18件: 6, 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬
403 Oxygen supplementation Oxygen 1件: D00003 💬 - - 1件: 86 💬
404 Oxygen, liquid Oxygen 1件: D00003 💬 - - 2件: 86, 88 💬
405 Pah - - - - 3件: 49, 53, 86 💬
406 Pah medication - - - - 1件: 86 💬
407 Parenteral remodulin (treprostinil) injection Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
408 Pb1046 - - - - 1件: 86 💬
409 Pb1046 subcutaneous injection - - - - 1件: 86 💬
410 Pb1046, vip-elp1-120, vasomera - - - - 1件: 86 💬
411 Pemziviptadil (pb1046) - - - - 1件: 86 💬
412 Pemziviptadil (pb1046) injection - - - - 1件: 86 💬
413 Pf-00489791 PF-00489791 - - - 1件: 86 💬
414 Ph-combination therapy - - - - 2件: 86, 88 💬
415 Ph-monotherapy - - - - 2件: 86, 88 💬
416 Pioglitazone Pioglitazone 2件: D00945, D08378 💬 1件: PPARG 💬 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
417 Placebo - - - - 26件: 3, 5, 6, 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
418 Plx-pad Placental Mesenchymal Stem Cells - - - 1件: 86 💬
419 Prednisone Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 47件: 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
420 Procedure: b-lines se - - - - 3件: 58, 86, 215 💬
421 Procedure: coronary flow reserve se - - - - 3件: 58, 86, 215 💬
422 Procedure: diastolic function se - - - - 3件: 58, 86, 215 💬
423 Procedure: left ventricular contractile reserve se - - - - 3件: 58, 86, 215 💬
424 Procedure: left ventricular outflow tract gradient se - - - - 3件: 58, 86, 215 💬
425 Procedure: mitral regurgitation se - - - - 3件: 58, 86, 215 💬
426 Procedure: no gas - - - - 2件: 86, 88 💬
427 Procedure: padn - - - - 1件: 86 💬
428 Procedure: pulmonary hemodynamics se - - - - 3件: 58, 86, 215 💬
429 Procedure: sham padn - - - - 1件: 86 💬
430 Prostacyclin Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
431 Puri-nethol - - - - 3件: 86, 96, 97 💬
432 Q4w gma301 iv injections (1000 mg) - - - - 1件: 86 💬
433 Q4w gma301 iv injections (300 mg) - - - - 1件: 86 💬
434 Q4w gma301 iv injections (600 mg) - - - - 1件: 86 💬
435 Qcc374 - - - - 1件: 86 💬
436 Qcc374 0.015 mg - - - - 1件: 86 💬
437 Qcc374 0.06 mg - - - - 1件: 86 💬
438 Qti571 - - - - 1件: 86 💬
439 Qutenza - - - - 1件: 86 💬
440 Qutenza (8% capsaicin) Capsaicin 1件: D00250 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 1件: 86 💬
441 Radiation: pet/ct scan: two pet scans using 1. c-11 hed and 2. n-13 ammonia or rubidium-82 Ammonia 1件: D02916 💬 - - 1件: 86 💬
442 Ralinepag Ralinepag 1件: D10725 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
443 Ranolazine Ranolazine 2件: D05700, D05701 💬 - - 6件: 2, 58, 86, 96, 113, 114 💬
444 Rapamycin Sirolimus 1件: D00753 💬 1件: MTOR 💬 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 18件: 2, 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬
445 Rapid dose titration group of subcutaneous treprostinil Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
446 Recombinant human angiotensin-converting enzyme 2 Angiotensin II 2件: D00150, D02014 💬 2件: AGTR1, AGTR2 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 86 💬
447 Recombinant human angiotensin-converting enzyme 2 (ace2), apn01 Angiotensin II 2件: D00150, D02014 💬 2件: AGTR1, AGTR2 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 86 💬
448 Remodulin - - - - 2件: 86, 88 💬
449 Remodulin (treprostinil sodium) Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
450 Remodulin® (treprostinil) 1 mg/ml solution for infusion Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
451 Remodulin® (treprostinil) 10 mg/ml solution for infusion Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
452 Remodulin® (treprostinil) 2.5 mg/ml solution for infusion Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
453 Remodulin® (treprostinil) 5 mg/ml solution for infusion Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
454 Revatio - - - - 3件: 85, 86, 113 💬
455 Revatio 10 mg/ml powder for oral suspension - - - - 1件: 86 💬
456 Revatio 20 mg film coated tablets - - - - 1件: 86 💬
457 Revatio 20 mg film-coated tablets - - - - 1件: 86 💬
458 Revatio 20 mg filmtabletten - - - - 1件: 86 💬
459 Revatio 20 mg, comprimidos recubiertos con película - - - - 1件: 86 💬
460 Revatio inyectable - - - - 1件: 86 💬
461 Revatio oral - - - - 1件: 86 💬
462 Revatio pos - - - - 1件: 86 💬
463 Revatio tablets - - - - 1件: 86 💬
464 Revatio ® 20 mg film-coated tablets - - - - 1件: 86 💬
465 Revatio® - - - - 1件: 86 💬
466 Riciguat group - - - - 1件: 86 💬
467 Rifampin Rifampicin 1件: D00211 💬 - - 5件: 6, 13, 84, 86, 299 💬
468 Riociguat Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 6件: 51, 84, 86, 88, 225, 299 💬
469 Riociguat (adempas, bay63-2521) Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 4件: 51, 86, 88, 299 💬
470 Riociguat (bay63-2521) Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 86 💬
471 Riociguat granules 0.3% for oral application Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 86 💬
472 Riociguat oral product Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 86 💬
473 Riociguat pill Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 86 💬
474 Ritonavir Ritonavir 1件: D00427 💬 - - 3件: 2, 86, 265 💬
475 Rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
476 Ro 47-0203 - - - - 4件: 51, 85, 86, 88 💬
477 Ro 47-0203 / act-050088 - - - - 1件: 86 💬
478 Ro-47-0203 - - - - 1件: 86 💬
479 Ro-47-0203/029 - - - - 1件: 86 💬
480 Ro47-0203 - - - - 1件: 86 💬
481 Ro47-0203 / act-050088 - - - - 2件: 51, 86 💬
482 Roactemra - - - - 9件: 40, 41, 46, 51, 86, 107, 266, 271, 331 💬
483 Rt234 - vardenafil inhalation powder Vardenafil 3件: D02731, D03260, D08668 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
484 Rta 402 - - - - 3件: 67, 86, 218 💬
485 Rubidium Rubidium - - - 2件: 84, 86 💬
486 Rvg 33865 - - - - 1件: 86 💬
487 Rvt-1201 - - - - 1件: 86 💬
488 Salbutamol Salbutamol 1件: D02147 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 9件: 3, 11, 49, 85, 86, 111, 228, 256, 299 💬
489 Saline - - - - 10件: 6, 13, 17, 53, 67, 78, 86, 97, 168, 299 💬
490 Sapropterin Sapropterin 1件: D08505 💬 - - 3件: 86, 124, 240 💬
491 Sapropterin dihydrochloride (6r-bh4) Sapropterin 1件: D08505 💬 - - 1件: 86 💬
492 Saquinavir Saquinavir 2件: D00429, D01160 💬 - - 2件: 86, 265 💬
493 Saquinavir and ritonavir Ritonavir 3件: D00427, D00429, D01160 💬 - - 1件: 86 💬
494 Sauerstoff - - - - 2件: 86, 88 💬
495 Selexipag Selexipag 1件: D09994 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 5件: 51, 70, 84, 86, 88 💬
496 Selexipag (uptravi) Selexipag 1件: D09994 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
497 Selexipag, act-293987 (ns-304) Selexipag 1件: D09994 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
498 Selonsertib Selonsertib 1件: D10988 💬 1件: MAP3K5 💬 17件: Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Fluid shear stress and atherosclerosis, Huntington disease, MAPK signaling pathway, Neurotrophin signaling pathway, Non-alcoholic fatty liver disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Protein processing in endoplasmic reticulum, Sphingolipid signaling pathway, Spinocerebellar ataxia, TNF signaling pathway, Thermogenesis, Tight junction 1件: 86 💬
499 Seralutinib - - - - 1件: 86 💬
500 Serine Serine 1件: D00016 💬 - - 3件: 2, 6, 86 💬
501 Sham o2 (medical air) Medical air - - - 1件: 86 💬
502 Sildenaf - - - - 1件: 86 💬
503 Sildenafil Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
504 Sildenafil (as citrate) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
505 Sildenafil (revatio) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
506 Sildenafil (revatio) 20 mg tid Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
507 Sildenafil 20mg Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 2件: 51, 86 💬
508 Sildenafil 20mg and bosentan 62.5mg Bosentan 4件: D01227, D02229, D07538, D08514 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 2件: 51, 86 💬
509 Sildenafil citrate Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 4件: 51, 85, 86, 225 💬
510 Sildenafil citrate (uk-92,480) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
511 Sildenafil filmtabletten Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
512 Sildenafil singly or in association with bosentan Bosentan 4件: D01227, D02229, D07538, D08514 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
513 Sildenafilo Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
514 Simvastatin Simvastatin 1件: D00434 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 21件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
515 Simvastatin 40 mg Simvastatin 1件: D00434 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 1件: 86 💬
516 Simvastatin 40 mg tablets Simvastatin 1件: D00434 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 1件: 86 💬
517 Sitaxentan Sitaxentan 1件: D07171 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
518 Sitaxentan sodium Sitaxentan 1件: D07171 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
519 Sitaxsentan Sitaxentan 1件: D07171 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
520 Sitaxsentan alone Sitaxentan 1件: D07171 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
521 Sitaxsentan and sildenafil Sildenafil 3件: D02229, D07171, D08514 💬 2件: EDNRA, PDE5A 💬 9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
522 Sitaxsentan sodium Sitaxentan 1件: D07171 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
523 Slow dose titration group of subcutaneous treprostinil Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
524 Sodium nitrite Nitrite - - - 2件: 86, 299 💬
525 Sodium nitrite inhalation solution Nitrite - - - 1件: 86 💬
526 Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth Dextrose, unspecified form 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
527 Sorafenib Sorafenib 2件: D06272, D08524 💬 8件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 87件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 2件: 34, 86 💬
528 Sotatercept Sotatercept 1件: D09670 💬 1件: ACVR2A 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 2件: 86, 284 💬
529 Spironolactone Spironolactone 1件: D00443 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 7件: 58, 67, 86, 113, 210, 218, 225 💬
530 Spironolactone and conivaptan Conivaptan 3件: D00443, D01236, D07748 💬 3件: AVPR1A, AVPR2, NR3C2 💬 6件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 1件: 86 💬
531 Spironolactone captopril carvedilol Captopril 4件: D00251, D00255, D00443, D03415 💬 7件: ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬 18件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
532 Sti571 - - - - 2件: 51, 86 💬
533 Subcutaneous and intravenous prostacyclin Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
534 Subcutaneous treprostinil Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
535 Sugar pill - - - - 8件: 5, 6, 49, 67, 70, 86, 206, 210 💬
536 Sulfasalazine Sulfasalazine 1件: D00448 💬 - - 4件: 46, 86, 94, 271 💬
537 Sulfate Sulfate ion - - - 25件: 2, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬
538 Tadalafil Tadalafil 1件: D02008 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 7件: 6, 51, 75, 84, 86, 113, 210 💬
539 Tadalafil 20 mg film-coated tablets Tadalafil 1件: D02008 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
540 Tadalafil 40 mg Tadalafil 1件: D02008 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
541 Tadalafil and ambrisentan upfront combination therapy Ambrisentan 2件: D02008, D07077 💬 2件: EDNRA, PDE5A 💬 9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 2件: 51, 86 💬
542 Tadalafil oral suspension Tadalafil 1件: D02008 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
543 Tadalafil, placebo Tadalafil 1件: D02008 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
544 Tadalafil- tablet or oral suspension Tadalafil 1件: D02008 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
545 Tadalafilo Tadalafil 1件: D02008 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
546 Tamoxifen Tamoxifen 2件: D00966, D08559 💬 2件: ESR1, ESR2 💬 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 4件: 2, 86, 113, 227 💬
547 Tasigna - - - - 2件: 34, 86 💬
548 Tasigna® - - - - 1件: 86 💬
549 Tasigna® 150 mg - - - - 1件: 86 💬
550 Tbd - - - - 4件: 19, 86, 276, 299 💬
551 Tegaderm - - - - 1件: 86 💬
552 Terguride Terguride 1件: D01348 💬 2件: DRD2, PRL 💬 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 2件: 51, 86 💬
553 Terguride 0,5mg tablet Terguride 1件: D01348 💬 2件: DRD2, PRL 💬 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 1件: 86 💬
554 Terguride 0.5 mg tablet Terguride 1件: D01348 💬 2件: DRD2, PRL 💬 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 1件: 86 💬
555 Tezosentan Tezosentan - - - 1件: 86 💬
556 The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: - - - - 1件: 86 💬
557 The pops study is collecting pk data on children prescribed the following drugs of interest per standard of care: - - - - 1件: 86 💬
558 Thelin - - - - 1件: 86 💬
559 Threonine Threonine 1件: D00041 💬 - - 3件: 86, 96, 97 💬
560 Thrombin Thrombin 1件: D00090 💬 - - 2件: 86, 88 💬
561 Tocilizumab Tocilizumab 1件: D02596 💬 1件: IL6R 💬 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 18件: 2, 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
562 Tpn171h - - - - 1件: 86 💬
563 Traclear - - - - 1件: 86 💬
564 Tracleer - - - - 8件: 13, 51, 84, 85, 86, 88, 210, 211 💬
565 Tracleer 62,5 mg comprimidos recubiertos con película - - - - 1件: 86 💬
566 Tracleer 62,5mg 56cpr riv. - - - - 1件: 86 💬
567 Tracleer*125mg 56cpr riv. - - - - 2件: 51, 86 💬
568 Tracleer*56cpr riv 125mg - - - - 3件: 51, 86, 88 💬
569 Tracleer® - - - - 1件: 86 💬
570 Transdihydrolisuride - - - - 2件: 51, 86 💬
571 Tre - - - - 1件: 86 💬
572 Treprosinil diethanolamine - - - - 1件: 86 💬
573 Treprostin - - - - 1件: 86 💬
574 Treprostinil Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 6件: 51, 84, 85, 86, 88, 210 💬
575 Treprostinil dietanolamina Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
576 Treprostinil diethanolamine Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 2件: 51, 86 💬
577 Treprostinil diolamine Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
578 Treprostinil inhalation powder Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
579 Treprostinil inhalations Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
580 Treprostinil injectable product Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
581 Treprostinil sodium Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 3件: 51, 86, 88 💬
582 Treprostinil sodium solution for inhalation Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
583 Treprostinil sodium, ut-15 Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
584 Treprostinil, ut-15, lrx-15, 15au81, bw a15au, u-62, 840 Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
585 Treprostinilo Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
586 Trimetazidine Trimetazidine 2件: D01606, D08642 💬 - - 2件: 58, 86 💬
587 Trk-100stp - - - - 1件: 86 💬
588 Tyrosine Tyrosine 1件: D00022 💬 - - 3件: 6, 86, 111 💬
589 Tyvaso - - - - 1件: 86 💬
590 Tyvaso inhalation solution - - - - 1件: 86 💬
591 Ubenimex Ubenimex 1件: D00087 💬 1件: ANPEP 💬 4件: Glutathione metabolism, Hematopoietic cell lineage, Metabolic pathways, Renin-angiotensin system 1件: 86 💬
592 Udenafil Udenafil 1件: D10027 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 2件: 86, 210 💬
593 Uk 092480 - - - - 1件: 86 💬
594 Uk-92,480 - - - - 1件: 86 💬
595 Uk-92,480-10 - - - - 1件: 86 💬
596 Uptravi - - - - 3件: 84, 86, 88 💬
597 Ut-15c - - - - 1件: 86 💬
598 Ut-15c (treprostinil diethanolamine) Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
599 Ut-15c 0.25 mg - - - - 1件: 86 💬
600 Ut-15c 1 mg - - - - 1件: 86 💬
601 Ut-15c 5 mg - - - - 1件: 86 💬
602 Ut-15c lp - - - - 1件: 86 💬
603 Ut-15c sr - - - - 2件: 51, 86 💬
604 Ut-15c sr (treprostinil diethanolamine) Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
605 Ut-15c-sr - - - - 2件: 51, 86 💬
606 Vardenafil Vardenafil 3件: D02731, D03260, D08668 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 3件: 13, 86, 299 💬
607 Vasomera (pb1046) injection - - - - 1件: 86 💬
608 Veletri - - - - 1件: 86 💬
609 Ventavis - - - - 1件: 86 💬
610 Ventavis (iloprost, bayq6256) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
611 Ventavis 10 - - - - 1件: 86 💬
612 Ventavis(iloprost) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
613 Viagra - - - - 3件: 86, 96, 225 💬
614 Vip - - - - 3件: 49, 51, 86 💬
615 Volibris - - - - 4件: 51, 85, 86, 88 💬
616 Volibris 10 mg comprimidos recubiertos con película - - - - 1件: 86 💬
617 Volibris 5 mg comprimidos recubiertos con película - - - - 1件: 86 💬
618 Volibris® (ambrisentan) Ambrisentan 1件: D07077 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
619 Volibris™ tablets - - - - 1件: 86 💬
620 Zamicastat Zamicastat - - - 1件: 86 💬

先頭へ